NXSTAGE PUREFLOW-B SOLUTION— 510(k) K042045
Substantially EquivalentNxstage Medical, Inc.
FDA 510(k) clearance K042045 for NXSTAGE PUREFLOW-B SOLUTION, Substantially Equivalent on 2004-08-27. Applicant: Nxstage Medical, Inc.. Device class: 2.
Clearance details
- Applicant
- Nxstage Medical, Inc.
- Product code
- Code KPO
- Device class
- Class 2
- Regulation
- 21 CFR 876.5820
- Advisory panel
- Gastroenterology, Urology
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Lawrence, MA, US
Recent devices under product code KPO
view allMore clearances from Nxstage Medical, Inc.
view allAdverse events under product code KPO
product code KPO- Death
- 14
- Malfunction
- 775
- Other
- 20
- Total
- 809
Source: openFDA MAUDE database, through . Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →
Recalls naming K042045
K-number listed on FDA's recall recordMatched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K042045.
Data sourced from openFDA. This site is unofficial and independent of the FDA.